VC  Sands Capital

https://sandscapitalventures.com





     Office Locations:

1000 Wilson Blvd., Suite 3000
Arlington, VA 22209
Phone: 703-562-4000

 

Stages:

  • Early


 

Industries:

  • Consumer Products & Services
  • Information Technology
  • Life Sciences & Healthcare

  •  

    Description:

    Sands Capital Ventures invests in promising businesses in three dynamic, high-growth markets: Life Sciences, Technology, and Global Consumer. The firm is the venture capital affiliate of Sands Capital Management, an investment firm founded in 1992 that manages long-only, concentrated public company portfolios.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Christy Steele Senior Associate
    Erin Soule CPA Director of Finance and Operations
    Frank Sands CFA CIO and CEO & Co-Founder
    Gene Riechers Venture Partner
    Ian Ratcliffe Managing Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      01/08/2021


      DiCE Molecules


      CA


      $80,000,000


      Series C


      12/16/2020


      StockX


      MI


      $275,000,000


      Series E


      10/28/2020


      Scopely


      CA


      $340,000,000


      Series E


      08/06/2020


      Taysha Gene Therapies


      TX


      $95,000,000


      Series B


     

    Portfolio companies include:


      908 Devices
        web link


      Allvision
        web link


      Anaplan
        web link


      AppDynamics
        web link


      Candel Therapeutics
        web link


      DataRobot
        web link


      DiCE Molecules
        web link


      Health Catalyst
        web link


      HUNGRY Marketplace
        web link


      Karuna Pharmaceuticals
        web link


      Kit Check
        web link


      Lending Club
        web link


      Modernizing Medicine
        web link


      MuleSoft
        web link


      Scopely
        web link


      Slack
        web link


      Stipple
        web link


      StockX
        web link


      Taysha Gene Therapies
        web link


      UiPath
        web link


      Upgrade
        web link


      Vesper
        web link


      Wirewheel
        web link


     

    Recent News: